01 5Nourianz
02 7Nouriast
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 25
2019 Revenue in Millions : 1
Growth (%) : 2,500
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 89
2019 Revenue in Millions : 92
Growth (%) : -3
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 38
2020 Revenue in Millions : 25
Growth (%) : 73
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 73
2020 Revenue in Millions : 89
Growth (%) : -7
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 49
2021 Revenue in Millions : 38
Growth (%) : 29
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 60
2021 Revenue in Millions : 73
Growth (%) : -18
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 106
2022 Revenue in Millions : 110
Growth (%) : 9
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 51
2022 Revenue in Millions : 60
Growth (%) : -5
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 82
2016 Revenue in Millions : 70
Growth (%) : 16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 85
2017 Revenue in Millions : 77
Growth (%) : 11%
